A clinically proven, bio-intelligent facial serum designed to visibly restore volume, smooth deep wrinkles, and firm skin affected by aging, weight loss, and lifestyle shifts
For comprehensive safety information, review our guide on IV therapy safety
Kidney outcomes in cardiovascular trials: Analyses from SUSTAIN-6, LEADER, and other trials consistently show reductions in kidney-related outcomes with GLP-1 treatment
The association between body mass index and neoadjuvant chemotherapy response in patients with breast cancer
Competitive athletes should be especially cautious
News Gilead Sciences acquires Ouro Medicines for over US$2 billion Gilead Sciences confirms a deal to take over Ouro Medicines, adding to a portfolio of therapies for autoimmune diseases